Outgoing APhA President Leal Commends Pharmacy for Commitment to Advocacy
Leal addressed APhA conference attendees at the opening general session.
Evaluating Pharmacist Attitudes Toward, Understanding of Biosimilars
Gaps exist in knowledge about interchangeability and substitutions.
Relieve Arthritis Pain, Improve Patient QOL With CBD
Patient confidence in CBD products—and pharmacist ability to provide counsel—increased during the study.
Conflict Between Patient, Provider in Managing the Chronic Pain and OUD
In rural settings, patients and providers are frequently reading from different scripts when it comes to managing these conditions
Gauging Pharmacists’ Comfort Immunizing Young Children
Recent changes in regulations mean that pharmacists are able to administer vaccines to children as young as 3.
Creating Opportunities for Collaboration Between Community, Health System Pharmacy
Cross-practice collaboration is one of the best ways to improve patient outcomes.
Best Practices for OTC Recommendations for Osteoarthritis
OTC guidelines for osteoarthritis have evolved over time.
Meeting Preview: APhA 2022
The American Pharmacists Association annual meeting will take place March 17 to March 22 in San Antonio, Texas.
Diabetes Treatment Guidelines, Practices Advance Despite COVID-19 Focus in Health Care
A session held during the American Pharmacists Association 2021 Annual Meeting and Exposition provided an update on diabetes practice changes and new treatments.
Community Pharmacies Well Equipped for COVID-19 POC Testing, But Barriers Remain
Survey results suggest independent pharmacies may be better positioned than chains to offer COVID-19 POC testing to their patients.
Develop a Plan for CBD Therapy
In a presentation from APhA2021, clinical pharmacist Danielle Fixon, PharmD, BCGP, BCPS, offers counseling tips for CBD products.
Expanding Scope of Practice Amid the COVID-19 Pandemic and Beyond
An update on COVID-19 advocacy activity and regulations affecting your pharmacy practice.
Analysis Explores Ketamine Use for Treatment of Migraines, Primary Headaches
Research presented during the APhA 2021 Annual Meeting and Exposition examined the clinical use of ketamine as an abortive therapy for migraines and primary headaches.
Netflix Docuseries Pharmacist Shares Story on Combating the Opioid Epidemic
Keynote speaker Dan Schneider, from the Netflix documentary “The Pharmacist,” discusses his story and mission to end the opioid epidemic.
Experts Examine the Many Factors of Pharmacist Burnout
“Are employers really stepping up to take care of their health providers? I think [that] is something that also probably needs to change.”
APhA2020 Virtual: Community Pharmacists Ready for Provider Status and Prescriptive Authority
Nearly 94% of survey respondents agreed that provider status is important for the future of pharmacy.
APhA Conference Coverage: Provider Status Widens, Reimbursements Stall
Key updates from the Seattle, WA, conference in March.
